Ad Alert

FDA to Citrus Fit Gold: Better Shape Up

The FDA's message to the makers of the dietary supplement is simple: Shape up or ship out.

Ad Alert

FDA to Citrus Fit Gold: Better Shape Up

UPDATE: In May 2018, the FDA sent Citrus Fit a “close out letter” acknowledging that the company had addressed the violations cited in the October 2014 warning letter. Our original ad alert follows.

The FDA’s message to the makers of Citrus Fit Gold is simple: Shape up or ship out.

In a warning letter dated Oct. 15, the agency said the dietary supplement contains a dangerous undeclared ingredient called sibutramine, which clinical data has shown to increase the risk of heart attack and stroke. Sibutramine was withdrawn from the U.S. market.

The letter also cites health claims in the product’s marketing relating to weight loss that classifies Citrus Fit Gold as a drug. But without FDA approval, which the dietary supplement does not have, that classification is illegal.

In its research, the FDA reviewed the website, www.citrusfit.com. That website has now been reduced to just the following message: “The official Citrus Fit will no longer be offering weight loss supplement pills. This is due to a large amount of product imitations in the market misleading the public. For enquiries please email [email protected]

For more information on dietary supplements click here.


You Might Be Interested In

B17

Ad Alert

B17

How Amazon steers consumers toward unproven and potentially dangerous products containing a fake vitamin called B17.